Summary
It has been ascertained that racemic 2,5-bis-(aminooxymethyl)-3,6-diketopiperazine, being a transformation product ofD,L-cycloserine, possesses the same effect againstMycobacterium tuberculosis asD,L-cycloserine itself.
Literatur
Ph. H. Hidy, E. B. Hodge, V. V. Young, R. L. Harned, G. A. Brewer, W. F. Phillips, W. F. Runge, H. E. Stavely, A. Pohland, H. Boaz undH. R. Sullivan, J. Amer. chem. Soc.77, 2345 (1955).
H. Bretschneider undW. Vetter, Mh. Chem.90, 779 (1959).
T. Aoki, Kekkaku32, 605 (1957); Chem. Abstr.52, 7427 (1958).
N. K. Kotschetkow, R. M. Chomutow, M. J. Karpeisski, E. J. Budowski undJ. S. Sseverin, Dokl. Akad. Nauk UdSSR126, 1132 (1959).
N. K. Kotschetkow, Österr. Chem. Z.62, 276 (1961).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Michalský, J., Čtvrtník, J., Horáková, Z. et al. Über die tuberkulostatische Aktivität von 2,5-Bis-(aminooxymethyl)-3,6-diketopiperazin, eines Umwandlungsproduktes des Cycloserins. Experientia 18, 217–218 (1962). https://doi.org/10.1007/BF02148308
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02148308